Transcription of active substance, excipient and primary container …
{{id}} {{{paragraph}}}
Example: bachelor of science
active substance, excipient and primary container …
6 March 2019. EMA/CHMP/CVMP/QWP/850374/2015. Committee for Medicinal Products for Human use (CHMP). Committee for Medicinal Products for Veterinary use (CVMP). Guideline on the sterilisation of the medicinal product, active substance , excipient and primary container Draft agreed by QWP and BWP December 2015. Adopted by CHMP for release for consultation January 2016. Adopted by CVMP for release for consultation February 2016. Start of public consultation 13 April 2016. End of consultation (deadline for comments) 13 October 2016. Agreed by BWP July 2018. Agreed by CAT September 2018. Agreed by QWP and GMDP IWG October 2018. Adopted by CHMP for publication 15 November 2018.
use (e.g. difficulties to differentiate between starting material, active substance and finished product in some cases, scarcity of starting materials/active substance/finished product (autologous products and matched-donor scenario), small volumes of production). The level of documentation that is expected to
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: